Optimization of Collagen Chemical Crosslinking to Restore Biocompatibility of Tissue-Engineered Scaffolds
Open Access
- 3 June 2021
- journal article
- research article
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (6), 832
- https://doi.org/10.3390/pharmaceutics13060832
Abstract
Collagen scaffolds, one of the most used biomaterials in corneal tissue engineering, are frequently crosslinked to improve mechanical properties, enzyme tolerance, and thermal stability. Crosslinkers such as 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) are compatible with tissues but provide low crosslinking density and reduced mechanical properties. Conversely, crosslinkers such as glutaraldehyde (GTA) can generate mechanically more robust scaffolds; however, they can also induce greater toxicity. Herein, we evaluated the effectivity of double-crosslinking with both EDC and GTA together with the capability of sodium metabisulfite (SM) and sodium borohydride (SB) to neutralize the toxicity and restore biocompatibility after crosslinking. The EDC-crosslinked collagen scaffolds were treated with different concentrations of GTA. To neutralize the free unreacted aldehyde groups, scaffolds were treated with SM or SB. The chemistry involved in these reactions together with the mechanical and functional properties of the collagen scaffolds was evaluated. The viability of the cells grown on the scaffolds was studied using different corneal cell types. The effect of each type of scaffold treatment on human monocyte differentiation was evaluated. One-way ANOVA was used for statistical analysis. The addition of GTA as a double-crosslinking agent significantly improved the mechanical properties and enzymatic stability of the EDC crosslinked collagen scaffold. GTA decreased cell biocompatibility but this effect was reversed by treatment with SB or SM. These agents did not affect the mechanical properties, enzymatic stability, or transparency of the double-crosslinked scaffold. Contact of monocytes with the different scaffolds did not trigger their differentiation into activated macrophages. Our results demonstrate that GTA improves the mechanical properties of EDC crosslinked scaffolds in a dose-dependent manner, and that subsequent treatment with SB or SM partially restores biocompatibility. This novel manufacturing approach would facilitate the translation of collagen-based artificial corneas to the clinical setting.Keywords
This publication has 47 references indexed in Scilit:
- Glutaraldehyde cross-linking of amniotic membranes affects their nanofibrous structures and limbal epithelial cell culture characteristicsInternational Journal of Nanomedicine, 2013
- Epoxy Cross-Linked Collagen and Collagen-Laminin Peptide Hydrogels as Corneal SubstitutesJournal of Functional Biomaterials, 2013
- A Biosynthetic Alternative to Human Donor Tissue for Inducing Corneal Regeneration: 24-Month Follow-Up of a Phase 1 Clinical StudyScience Translational Medicine, 2010
- Ocular Biocompatibility of Carbodiimide Cross-Linked Hyaluronic Acid Hydrogels for Cell Sheet Delivery CarriersJournal of Biomaterials Science, Polymer Edition, 2010
- Fabrication and characterization of cross-linked gelatin electro-spun nano-fibersJournal of Biomedical Science and Engineering, 2010
- Post-self-assembly experimentation on extruded collagen fibres for tissue engineering applicationsActa Biomaterialia, 2008
- Foreign body reaction to biomaterialsSeminars in Immunology, 2008
- Tissue engineering of heart valves by recellularization of glutaraldehyde-fixed porcine valves using bone marrow-derived cellsExperimental & Molecular Medicine, 2006
- Cross-Linking of Human Amniotic Membrane by GlutaraldehydeOphthalmic Research, 2004
- INACTIVATION OF GLUTARALDEHYDE BY REACTION WITH SODIUM BISULFITEJournal of Toxicology and Environmental Health, 1996